Avoid Fraud, Get The Facts, And Find The Best
Legal Name: GHOST TREE CAPITAL, LLC
Period of report:
Jun 30, 2019
Effectiveness Date:
Aug 14, 2019
| Security |
Shares Held / Principal Amount |
Market Value |
Option |
|
Sarepta Therapeutics Inc (803607100)
|
290,000 |
$44,066k |
|
|
SPDR SERIES TRUST (78464A870)
|
500,000 |
$40,000k |
Put |
|
INVESCO QQQ TR UNIT SER 1 (46090E103)
|
200,000 |
$36,000k |
Put |
|
BLUEPRINT MEDICINES CORP (09627Y109)
|
375,000 |
$35,374k |
|
|
MIRATI THERAPEUTICS INC (60468T105)
|
335,000 |
$34,505k |
|
|
ASCENDIS PHARMA A S (04351P101)
|
225,000 |
$25,909k |
|
|
AXSOME THERAPEUTICS INC (05464T104)
|
850,000 |
$21,888k |
|
|
ACADIA PHARMACEUTCLS (004225108)
|
750,000 |
$20,048k |
|
|
AMICUS THERAPEUTICS INC (03152W109)
|
1,450,000 |
$18,096k |
|
|
GLOBAL BLOOD THERAPEUTICS IN (37890U108)
|
300,000 |
$15,780k |
|
|
Argenx SE Sponsored ADR (04016X101)
|
100,000 |
$14,158k |
|
|
IMMUNOMEDICS INC (452907108)
|
800,000 |
$12,000k |
Call |
|
ALNYLAM PHARMACEUTICALS INC (02043Q107)
|
150,000 |
$10,884k |
|
|
BIOCRYST PHARMACEUTICALS (09058v103)
|
2,500,000 |
$9,475k |
|
|
RA PHARMACEUTICALS (74933V108)
|
300,000 |
$9,021k |
|
|
INVESCO CURNCYSHS SWISS FRAN (46138R108)
|
92,200 |
$8,751k |
|
|
CymaBay Therapeutics, Inc. (23257D103)
|
1,000,000 |
$7,160k |
|
|
ROCKET PHARMACEUTICALS INC (77313F106)
|
460,000 |
$6,900k |
|
|
KALVISTA PHARMACEUTICALS (483497103)
|
300,000 |
$6,645k |
|
|
VIEWRAY INC COM (92672L107)
|
750,000 |
$6,608k |
|
|
MILESTONE PHARMACEUTICALS IN (59935V107)
|
240,000 |
$6,516k |
|
|
Momenta Pharmaceutical Inc. (60877T100)
|
500,000 |
$6,225k |
|
|
PFIZER INC (717081103)
|
150,000 |
$6,150k |
Put |
|
ZYMEWORKS INC (98985W102)
|
275,000 |
$6,050k |
|
|
EPIZYME INC (29428V104)
|
465,000 |
$5,836k |
|
|
Sage Therapeutics Inc (78667J108)
|
30,000 |
$5,493k |
|
|
SPARK THERAPEUTICS INC (84652J103)
|
50,000 |
$5,119k |
|
|
ARVINAS INC (04335A105)
|
225,000 |
$4,948k |
|
|
BIOHAVEN PHARMACTL HLDG CO L (G11196105)
|
100,000 |
$4,379k |
|
|
KADMON HOLDINGS INC (48283N106)
|
2,100,000 |
$4,326k |
|
|
COHERUS BIOSCIENCES INC (19249H103)
|
175,000 |
$3,868k |
|
|
DICERNA PHARMACEUTICALS INC (253031108)
|
235,000 |
$3,701k |
|
|
Iovance Biotherapeutics Inc (462260100)
|
150,000 |
$3,678k |
|
|
ORCHARD THERAPEUTICS PLC (68570P101)
|
242,950 |
$3,399k |
|
|
CHIASMA INC (16706W102)
|
400,000 |
$2,988k |
|
|
UNIQURE N.V. (N90064101)
|
35,000 |
$2,735k |
|
|
Homology Medicines (438083107)
|
125,000 |
$2,446k |
|
|
PROTAGONIST THERAPEUTICS INC (74366E102)
|
200,000 |
$2,422k |
|
|
ODONATE THERAPEUTICS INC (676079106)
|
65,000 |
$2,385k |
|
|
ARQULE INC (04269E107)
|
200,000 |
$2,202k |
|
|
SOLID BIOSCIENCES (83422E105)
|
100,000 |
$575k |
|
|
ALLAKOS INC COM (01671P100)
|
10,500 |
$455k |
|
Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.
All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.
Recently Searched Firms
Please note: Search data is accumulated by 3rd party and refreshed once per day.